Analysts Bullish on Crinetics (CRNX) Amid Positive Clinical Trial for New Drug
Crinetics Pharmaceuticals Inc. (NASDAQ:CRNX) is one of the 13 hot stocks to buy with the highest upside potential. On January 30, Stifel raised its price target on Crinetics Pharmaceuticals Inc.








